Matches in SemOpenAlex for { <https://semopenalex.org/work/W47343861> ?p ?o ?g. }
- W47343861 endingPage "478" @default.
- W47343861 startingPage "467" @default.
- W47343861 abstract "During the period from April 2004 to December 2010, 358 patients underwent peptide receptor radionuclide therapy (PRRT) ((90)Y-DOTATATE, (177)Lu-DOTATATE, and (90)Y/(177)Lu-DOTATATE) in Poland.The majority of patients underwent (90)Y-DOTATATE therapy (n = 177) with progression-free survival (PFS)/time to progression (TTP) of 17-44 months and overall survival (OS) of 22-34.2 months. Twelve-month follow-up revealed stable disease (SD) in 46-60%, disease regression (RD) in 16-35%, disease progression (PD) in 7-17%, and complete remission (CR) in 3% of patients. In patients treated with (90)Y/(177)Lu-DOTATATE (n = 44), PFS/TTP was 24.2-28.3 months and OS was 49.8-52.8 months. Twelve-month follow-up showed SD in 62-70%, RD in 15-20%, and PD in 10-12% of patients. The treatment was well tolerated. No severe adverse events occurred. Grade 3 toxicity [in leucocytes (WBC) and thrombocytes (PLT)] was seen in 6-20% of patients treated with (90)Y-DOTATATE. In that group, renal toxicity grade 3 was seen in 5-12% and grade 4 in 3-8%. In patients treated with tandem therapy with (90)Y/(177)Lu-DOTATATE or (177)Lu-DOTATATE alone, hematological and renal toxicity grade 3 or 4 was not observed.The results indicate that PRRT with the procedures and isotopes used is an effective and safe therapy option for patients with metastatic or inoperable neuroendocrine tumors (NETs). Our results suggest that tandem therapy with (90)Y/(177)Lu-DOTATATE provides longer overall survival than single-isotope treatment. Hematological toxicity was rare in all treated patients. Renal toxicity grade 3 and 4 was observed only in the group treated with (90)Y-DOTATATE." @default.
- W47343861 created "2016-06-24" @default.
- W47343861 creator A5001567130 @default.
- W47343861 creator A5004941553 @default.
- W47343861 creator A5005327464 @default.
- W47343861 creator A5007773763 @default.
- W47343861 creator A5008837385 @default.
- W47343861 creator A5010530541 @default.
- W47343861 creator A5021581586 @default.
- W47343861 creator A5047524962 @default.
- W47343861 creator A5052029541 @default.
- W47343861 creator A5054571679 @default.
- W47343861 creator A5062377015 @default.
- W47343861 creator A5069445133 @default.
- W47343861 creator A5078926366 @default.
- W47343861 creator A5082416504 @default.
- W47343861 date "2012-08-24" @default.
- W47343861 modified "2023-10-18" @default.
- W47343861 title "Polish Experience in Peptide Receptor Radionuclide Therapy" @default.
- W47343861 cites W1480909434 @default.
- W47343861 cites W1935825021 @default.
- W47343861 cites W1982055976 @default.
- W47343861 cites W1984882652 @default.
- W47343861 cites W1987373615 @default.
- W47343861 cites W1992543080 @default.
- W47343861 cites W2002418975 @default.
- W47343861 cites W2010764532 @default.
- W47343861 cites W2012600554 @default.
- W47343861 cites W2016356824 @default.
- W47343861 cites W2020347413 @default.
- W47343861 cites W2024035978 @default.
- W47343861 cites W2027511464 @default.
- W47343861 cites W2040531770 @default.
- W47343861 cites W2065594133 @default.
- W47343861 cites W2092047830 @default.
- W47343861 cites W2125398839 @default.
- W47343861 cites W2128967036 @default.
- W47343861 cites W2160185994 @default.
- W47343861 cites W4296766361 @default.
- W47343861 doi "https://doi.org/10.1007/978-3-642-27994-2_26" @default.
- W47343861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22918776" @default.
- W47343861 hasPublicationYear "2012" @default.
- W47343861 type Work @default.
- W47343861 sameAs 47343861 @default.
- W47343861 citedByCount "11" @default.
- W47343861 countsByYear W473438612013 @default.
- W47343861 countsByYear W473438612014 @default.
- W47343861 countsByYear W473438612016 @default.
- W47343861 countsByYear W473438612017 @default.
- W47343861 countsByYear W473438612021 @default.
- W47343861 crossrefType "book-chapter" @default.
- W47343861 hasAuthorship W47343861A5001567130 @default.
- W47343861 hasAuthorship W47343861A5004941553 @default.
- W47343861 hasAuthorship W47343861A5005327464 @default.
- W47343861 hasAuthorship W47343861A5007773763 @default.
- W47343861 hasAuthorship W47343861A5008837385 @default.
- W47343861 hasAuthorship W47343861A5010530541 @default.
- W47343861 hasAuthorship W47343861A5021581586 @default.
- W47343861 hasAuthorship W47343861A5047524962 @default.
- W47343861 hasAuthorship W47343861A5052029541 @default.
- W47343861 hasAuthorship W47343861A5054571679 @default.
- W47343861 hasAuthorship W47343861A5062377015 @default.
- W47343861 hasAuthorship W47343861A5069445133 @default.
- W47343861 hasAuthorship W47343861A5078926366 @default.
- W47343861 hasAuthorship W47343861A5082416504 @default.
- W47343861 hasConcept C126322002 @default.
- W47343861 hasConcept C141071460 @default.
- W47343861 hasConcept C170493617 @default.
- W47343861 hasConcept C197934379 @default.
- W47343861 hasConcept C2776694085 @default.
- W47343861 hasConcept C2779066768 @default.
- W47343861 hasConcept C2780739268 @default.
- W47343861 hasConcept C29730261 @default.
- W47343861 hasConcept C2993559085 @default.
- W47343861 hasConcept C3017732841 @default.
- W47343861 hasConcept C71924100 @default.
- W47343861 hasConcept C90924648 @default.
- W47343861 hasConceptScore W47343861C126322002 @default.
- W47343861 hasConceptScore W47343861C141071460 @default.
- W47343861 hasConceptScore W47343861C170493617 @default.
- W47343861 hasConceptScore W47343861C197934379 @default.
- W47343861 hasConceptScore W47343861C2776694085 @default.
- W47343861 hasConceptScore W47343861C2779066768 @default.
- W47343861 hasConceptScore W47343861C2780739268 @default.
- W47343861 hasConceptScore W47343861C29730261 @default.
- W47343861 hasConceptScore W47343861C2993559085 @default.
- W47343861 hasConceptScore W47343861C3017732841 @default.
- W47343861 hasConceptScore W47343861C71924100 @default.
- W47343861 hasConceptScore W47343861C90924648 @default.
- W47343861 hasLocation W473438611 @default.
- W47343861 hasLocation W473438612 @default.
- W47343861 hasOpenAccess W47343861 @default.
- W47343861 hasPrimaryLocation W473438611 @default.
- W47343861 hasRelatedWork W2050083847 @default.
- W47343861 hasRelatedWork W2126994277 @default.
- W47343861 hasRelatedWork W2414683342 @default.
- W47343861 hasRelatedWork W2594179990 @default.
- W47343861 hasRelatedWork W2790526699 @default.